BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27776661)

  • 1. Non-palpable incidentally found testicular tumors: Differentiation between benign, malignant, and burned-out tumors using dynamic contrast-enhanced MRI.
    El Sanharawi I; Correas JM; Glas L; Ferlicot S; Izard V; Ducot B; Bellin MF; Benoît G; Rocher L
    Eur J Radiol; 2016 Nov; 85(11):2072-2082. PubMed ID: 27776661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of Benign from Malignant Adnexal Masses by Dynamic Contrast-Enhanced MRI (DCE-MRI): Quantitative and Semi-quantitative analysis at 3-Tesla MRI.
    Gity M; Parviz S; Saligheh Rad H; Fathi Kazerooni A; Shirali E; Shakiba M; Baikpour M
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1073-1079. PubMed ID: 31030476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast-enhanced and diffusion-weighted MR imaging in the characterisation of small, non-palpable solid testicular tumours.
    Manganaro L; Saldari M; Pozza C; Vinci V; Gianfrilli D; Greco E; Franco G; Sergi ME; Scialpi M; Catalano C; Isidori AM
    Eur Radiol; 2018 Feb; 28(2):554-564. PubMed ID: 28856410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign or Malignant Characterization of Soft-Tissue Tumors by Using Semiquantitative and Quantitative Parameters of Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Zhang Y; Yue B; Zhao X; Chen H; Sun L; Zhang X; Hao D
    Can Assoc Radiol J; 2020 Feb; 71(1):92-99. PubMed ID: 32062994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative and quantitative contrast-enhanced ultrasonography for the characterisation of non-palpable testicular tumours.
    Luzurier A; Maxwell F; Correas JM; Benoit G; Izard V; Ferlicot S; Teglas JP; Bellin MF; Rocher L
    Clin Radiol; 2018 Mar; 73(3):322.e1-322.e9. PubMed ID: 29122221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced subtraction MRI for characterizing intratesticular mass lesions.
    Tsili AC; Argyropoulou MI; Astrakas LG; Ntoulia EA; Giannakis D; Sofikitis N; Tsampoulas K
    AJR Am J Roentgenol; 2013 Mar; 200(3):578-85. PubMed ID: 23436847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential diagnosis of nonpalpable testicular lesions: qualitative and quantitative contrast-enhanced US of benign and malignant testicular tumors.
    Isidori AM; Pozza C; Gianfrilli D; Giannetta E; Lemma A; Pofi R; Barbagallo F; Manganaro L; Martino G; Lombardo F; Cantisani V; Franco G; Lenzi A
    Radiology; 2014 Nov; 273(2):606-18. PubMed ID: 24968192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of pancreatic ductal adenocarcinoma from other pancreatic solid lesions.
    Liu K; Xie P; Peng W; Zhou Z
    J Comput Assist Tomogr; 2014; 38(5):681-6. PubMed ID: 24943251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent diffusion coefficient values and dynamic contrast enhancement patterns in differentiating seminomas from nonseminomatous testicular neoplasms.
    Tsili AC; Sylakos A; Ntorkou A; Stavrou S; Astrakas LG; Sofikitis N; Argyropoulou MI
    Eur J Radiol; 2015 Jul; 84(7):1219-26. PubMed ID: 25937261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating between benign and malignant sinonasal lesions using dynamic contrast-enhanced MRI and intravoxel incoherent motion.
    Jiang J; Xiao Z; Tang Z; Zhong Y; Qiang J
    Eur J Radiol; 2018 Jan; 98():7-13. PubMed ID: 29279173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of multi-parametric MRI to differentiate benign sex cord stromal tumors from malignant (non-stromal and stromal) testicular neoplasms.
    Khanna M; Abualruz AR; Yadav SK; Mafraji M; Al-Rumaihi K; Al-Bozom I; Kumar D; Tsili AC; Schieda N
    Abdom Radiol (NY); 2021 Jan; 46(1):319-330. PubMed ID: 32572513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The value of dynamic contrast-enhanced MRI in the differentiation between benign and malignant lacrimal epithelial tumors].
    Wang YZ; Xian JF; Wang XY; Guo J; Song LY
    Zhonghua Yi Xue Za Zhi; 2023 Aug; 103(31):2427-2432. PubMed ID: 37599217
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis of Spinal Lesions Using Heuristic and Pharmacokinetic Parameters Measured by Dynamic Contrast-Enhanced MRI.
    Lang N; Yuan H; Yu HJ; Su MY
    Acad Radiol; 2017 Jul; 24(7):867-875. PubMed ID: 28162875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orbital benign and malignant lymphoproliferative disorders: Differentiation using semi-quantitative and quantitative analysis of dynamic contrast-enhanced magnetic resonance imaging.
    Hu H; Xu XQ; Liu H; Hong XN; Shi HB; Wu FY
    Eur J Radiol; 2017 Mar; 88():88-94. PubMed ID: 28189215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Resolution Diffusion-Weighted Imaging Improves the Diagnostic Accuracy of Dynamic Contrast-Enhanced Sinonasal Magnetic Resonance Imaging.
    Wang F; Sha Y; Zhao M; Wan H; Zhang F; Cheng Y; Tang W
    J Comput Assist Tomogr; 2017; 41(2):199-205. PubMed ID: 27560026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
    Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
    Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of grade II and III oligodendrogliomas from grade II and III astrocytomas: a histogram analysis of perfusion parameters derived from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI.
    Lee JY; Ahn KJ; Lee YS; Jang JH; Jung SL; Kim BS
    Acta Radiol; 2018 Jun; 59(6):723-731. PubMed ID: 28862024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological and dynamic contrast enhanced MR imaging features for the differentiation of chordoma and giant cell tumors in the Axial Skeleton.
    Lang N; Su MY; Xing X; Yu HJ; Yuan H
    J Magn Reson Imaging; 2017 Apr; 45(4):1068-1075. PubMed ID: 27490009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histogram analysis of dynamic contrast-enhanced magnetic resonance imaging in the differential diagnosis of parotid tumors.
    Xiang S; Ren J; Xia Z; Yuan Y; Tao X
    BMC Med Imaging; 2021 Dec; 21(1):194. PubMed ID: 34920706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of dynamic contrast-enhanced MRI in characterizing complex ovarian tumors.
    Li HM; Qiang JW; Ma FH; Zhao SH
    J Ovarian Res; 2017 Jan; 10(1):4. PubMed ID: 28088245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.